United Kingdom· GB-APID-19592711000001106
Olanzapine 20mg tablets
A olanzapine product containing olanzapine, registered in United Kingdom by Dr Reddy's Laboratories (UK) Ltd. The same ATC class is registered in 18 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Olanzapine is registered in 18 of 19 countries.
Countries holding a registration under ATC N05AH03 (olanzapine), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 11 of them publish a price we can compare per daily dose
Olanzapine · ATC N05AH03
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of olanzapine costs, country by country.
Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.17 in United States to $3.34 in Switzerland — a ×19 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Olanzapine · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- CH Switzerland$3.34
- IT Italy$1.59
- FR France$0.63
- US United States$0.17 (acquisition cost)
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Olanzapine
- Manufacturer
- Dr Reddy's Laboratories (UK) Ltd
- Country
- United Kingdom (GB)
- ATC code
- N05AH03
- ATC class
- Olanzapine
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin05036072004733
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
481 interactions on record for olanzapine.
Graded by severity as the source publishes them — 14 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Olanzapine · interactions on record
481 records
- 14 severe
- 292 moderate
- 3 minor
- 137 info
Most severe, free to view
- MetoclopramideA03FA01severe
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium chlorideB05XA01severe
35 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under N05AH03
Olanzapine, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bc87062e-0ec9-4cf6-a38c-61c14b24b514 GET /v1/drugs/bc87062e-0ec9-4cf6-a38c-61c14b24b514?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "19592711000001106",
"desc": "Olanzapine 20mg tablets (Dr Reddy's Laboratories (UK) Ltd)",
"form": "Oral tablet",
"vpid": "42275911000001105",
"source": "dmd",
"vtm_id": "776977006",
"strength": "20 mg",
"substance": "Olanzapine",
"ingredient": "Olanzapine",
"supplier_code": "3313111000001102"
}See everything about olanzapine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.